Log In
Print
BCIQ
Print
Print this Print this
 

Captisol-enabled topiramate injection

Also known as: topiramate

  Manage Alerts
Collapse Summary General Information
Company Ligand Pharmaceuticals Inc.
DescriptionCaptisol-enabled topiramate injection
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSeizures
Indication DetailsTreat epileptic seizures; Treat partial onset or primary generalized tonic-clonic seizures in hospitalized epilepsy patients who are unable to take oral topiramate
Regulatory Designation

U.S. - Orphan Drug (Treat partial onset or primary generalized tonic-clonic seizures in hospitalized epilepsy patients who are unable to take oral topiramate)

Partner

CURx Pharmaceuticals Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today